Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation

25Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Antibodies directed against human respiratory syncytial virus (HRSV) glycoproteins were depleted from a commercial immunoglobulin preparation (RespiGam) by two different methods. The first method consisted of repeated adsorption of RespiGam to Sepharose beads with covalently bound soluble forms of the two major viral glycoproteins (F or G). The second method consisted of adsorption of immunoglobulins to live cells expressing F or G glycoproteins on their surfaces after infection with vaccinia virus recombinants. While the first method removed efficiently antibodies that reacted with F and/or G glycoproteins by ELISA, it was inefficient in the elimination of anti-HRSV neutralizing antibodies. In contrast, the second method removed efficiently anti-HRSV antibodies that both reacted by ELISA and neutralized virus infectivity. These results confirm that human neutralizing antibodies are directed exclusively against HRSV F and G glycoproteins, and, they raise the possibility that F and G glycoproteins inserted into cell membranes differ antigenically from their soluble forms linked covalently to Sepharose beads. © 2005 Wiley-Liss, Inc.

References Powered by Scopus

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants

1963Citations
N/AReaders
Get full text

Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus

1318Citations
N/AReaders
Get full text

Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children

651Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

226Citations
N/AReaders
Get full text

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

116Citations
N/AReaders
Get full text

Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation

112Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sastre, P., Melero, J. A., García-Barreno, B., & Palomo, C. (2005). Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation. Journal of Medical Virology, 76(2), 248–255. https://doi.org/10.1002/jmv.20349

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

61%

Professor / Associate Prof. 4

22%

Researcher 3

17%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 5

36%

Biochemistry, Genetics and Molecular Bi... 4

29%

Medicine and Dentistry 3

21%

Immunology and Microbiology 2

14%

Save time finding and organizing research with Mendeley

Sign up for free